SCYNEXIS (SCYX) Earnings Date & Reports

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

SCYX is expected to report earnings to rise 133.33% to -20 cents per share on May 08

Q1'25

Est.

$-0.21

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.08

Q2'24

Missed

by $0.15

Q1'24

Beat

by $0.19

The last earnings report on March 12 showed earnings per share of -9 cents, beating the estimate of -15 cents. With 68.43K shares outstanding, the current market capitalization sits at 55.88M.

View a ticker or compare two or three

Compare

SCYX